The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model

Biomaterials

Volumn 27, Issue 26, 2006, Pages 4627-4634

  Alt, Volker ^a   Bitschnau, Achim ^a   Österling, Jana ^a   Sewing, Andreas ^b   Meyer, Christof ^a   Kraus, Ralf ^a   Meissner, Stefan A ^a   Wenisch, Sabine ^a   Domann, Eugen ^a   Schnettler, Reinhard ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b Biomet Deutschland GmbH   (Germany)

Author keywords

Antibacterial; Arthroplasty; Infection; Surface treatment

Indexed keywords

ANTIBIOTICS; BONE CEMENT; COATINGS; HYDROXYAPATITE; MICROBIOLOGY; SURFACE TREATMENT;

ANTIBACTERIAL EFFECTS; ARTHROPLASTY; INFECTION; JOINT ARTHROPLASTY;

PROSTHETICS;

DNA; GENTAMICIN; HYDROXYAPATITE;

AGAR MEDIUM; ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BIOCOMPATIBILITY; COATED PARTICLE; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL INFECTION; HISTOPATHOLOGY; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; INOCULATION; JOINT PROSTHESIS; MATERIAL COATING; METAL IMPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROSTHESIS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; RABBIT; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; TISSUE SECTION; TREATMENT OUTCOME;

ANIMALS; ARTHROPLASTY; BONE AND BONES; BONE CEMENTS; BONE WIRES; COATED MATERIALS, BIOCOMPATIBLE; DISEASE MODELS, ANIMAL; GENTAMICINS; HYDROXYAPATITES; JOINT PROSTHESIS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ANIMALIA; BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS; STAPHYLOCOCCUS AUREUS;

EID: 33646876196     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.04.035     Document Type: Article

References (29)

1. Berger R.A., Jacobs J.J., Quigley L.R., Rosenberg A.G., and Galante J.O. Primary cementless acetabular reconstruction in patients younger than 50 years old. 7- to 11-year results. Clin Orthop Relat Res 344 (1997) 216-226
2. Havelin L.I., Engesaeter L.B., Espehaug B., Furnes O., Lie S.A., and Vollset S.E. The Norwegian Arthroplasty Register: 11 years and 73,000 arthroplasties. Acta Orthop Scand 71 (2000) 337-353
3. Oosterbos C.J., Rahmy A.I., Tonino A.J., and Witpeerd W. High survival rate of hydroxyapatite-coated hip prostheses: 100 consecutive hips followed for 10 years. Acta Orthop Scand 75 (2004) 127-133
4. Kantlehner M., Schaffner P., Finsinger D., Meyer J., Jonczyk A., Diefenbach B., et al. Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem 18 (2000) 107-114
5. Kantlehner M., Finsinger D., Meyer J., Schaffner P., Jonczyk A., et al. Selective RGD-mediated adhesion of osteoblasts at surfaces of implants. Angew Chem Int Ed 38 (1999) 560-562
6. Bernhardt R., van den Dolder J., Bierbaum S., Beutner R., Scharnweber D., Jansen J., et al. Osteoconductive modifications of Ti-implants in a goat defect model: characterization of bone growth with SR muCT and histology. Biomaterials 26 (2005) 3009-3019
7. Klemm K. Gentamicin-PMMA-Kugeln in der Behandlung abszedierender Knochen- und Weichteilinfektionen. Zentralbl Chir 104 (1979) 934-942
8. Buchholz H.W., and Engelbrecht H. Über die Depotwirkung einiger Antibiotika bei Vermischung mit dem Kunstharz Palacos. Chirurg 40 (1970) 511-515
9. Engesaeter L.B., Lie S.A., Espehaug B., Furnes O., Vollset S.E., and Havelin L.I. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 74 (2003) 644-651
10. Vogely H.C., Oosterbos C.J., Puts E.W., Nijhof M.W., Nikkels P.G., Fleer A., et al. Effects of hydrosyapatite coating on Ti-6A1-4V implant-site infection in a rabbit tibial model. J Orthop Res 18 (2000) 485-493
11. Campbell A.A., Song L., Li X.S., Nelson B.J., Bottoni C., Brooks D.E., et al. Development, characterization, and anti-microbial efficacy of hydroxyapatite-chlorhexidine coatings produced by surface-induced mineralization. J Biomed Mater Res 53 (2000) 400-407
12. Stigter M., de Groot K., and Layrolle P. Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium. Biomaterials 23 (2002) 4143-4153
13. Stigter M., Bezemer J., de Groot K., and Layrolle P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 99 (2004) 127-137
14. Rössler S., Sewing A., Stolzel M., Born R., Scharnweber D., Dard M., et al. Electrochemically assisted deposition of thin calcium phosphate coatings at near-physiological pH and temperature. J Biomed Mater Res A 64 (2003) 655-663
15. Steckelberg JM, Osmon DR. Prosthetic joint infection. In: Waldvogel FA, Bisno AL, editors. Infections associated with indwelling devices. 3rd ed. Washington, DC, USA: ASM Press. p. 173-209.
16. Lucke M., Schmidmaier G., Sadoni S., Wildemann B., Schiller R., Haas N.P., et al. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 32 (2003) 521-531
17. Nijhof M.W., Dhert W.J., Fleer A., Vogely H.C., and Verbout A.J. Prophylaxis of implant-related staphylococcal infections using tobramycin-containing bone cement. J Biomed Mater Res 52 (2000) 754-761
18. Linhardt F., Ziebuhr W., Meyer P., Witte W., and Hacker J. Pulsed-field gel electrophoresis of genomic restriction fragments as a tool for the epidemiological analysis of Staphylococcus aureus and coagulase-negative staphylococci. FEMS Microbiol Lett 74 (1992) 181-185
19. Donath K., and Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissues. The Sage-Schliff (sawing and grinding) technique. J Oral Pathol 11 (1982) 318-326
20. Hanssen A.D., and Rand J.A. Evaluation and treatment of infection at the site of a total hip or knee arthroplasty. Instr Course Lect 48 (1999) 111-122
21. Kurtz S., Mowat F., Ong K., Chan N., Lau E., and Halpern M. Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002. J Bone Joint Surg Am 87 (2005) 1487-1497
22. Sculco T.P. The economic impact of an infected total joint arthroplasty. Instruct Course Lect 42 (1993) 349-356
23. Lucke M., Wildemann B., Sadoni S., Surke C., Schiller R., Stemberger A., et al. Systemic versus local application of gentamicin in prophylaxis of implant-related osteomyelitis in a rat model. Bone 36 (2005) 770-778
24. Radin S., Campbell J.T., Ducheyne P., and Cuckler J.M. Calcium phosphate ceramic coatings as carriers of vancomycin. Biomaterials 18 (1997) 777-782
25. van de Belt H., Neut D., Schenk W., van Horn J.R., van der Mei H.C., and Busscher H.J. Infection of orthopedic implants and the use of antibiotic-loaded bone cements. A review. Acta Orthop Scand 72 (2001) 557-571
26. Thornes B., Murray P., and Bouchier-Hayes D. Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. J Bone Joint Surg Br 84-B (2002) 758-760
27. Anguita-Alonso P., Hanssen A.D., Osmon D.R., Trampuz A., Steckelberg J.M., and Patel R. High rate of aminoglycoside resistance among staphylococci causing prosthetic joint infection. Clin Orthop Relat Res 439 (2005) 43-47
28. von Eiff C., Lindner N., Proctor R.A., Winkelmann W., and Peters G. Development of gentamicin-resistant small colony variants of S. aureus after implantation of gentamicin chains in osteomyelitis as a possible cause of recurrence. Z Orthop Ihre Grenzgeb 136 (1998) 268-271
29. Gristina A.G. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 237 (1987) 1588-1595